Atacicept Terminated Phase 2 Trials for Optic Neuritis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00624468Atacicept in Subjects With Optic Neuritis